Yayın:
Desferrioxamine effectively attenuates testicular tissue at the end of 3 h of ischemia but not in an equal period of reperfusion

dc.contributor.authorAyvaz, Suleyman
dc.contributor.authorInan, Mustafa
dc.contributor.authorAksu, Burhan
dc.contributor.authorKaraca, Turan
dc.contributor.authorCemek, Mustafa
dc.contributor.authorAyaz, Ahmet
dc.contributor.authorBasaran, Umit Nusret
dc.contributor.authorPul, Mehmet
dc.date.accessioned2026-06-27T13:30:46Z
dc.date.issued2014
dc.description.abstractObjective: To investigate the effect of desferrioxamine (DFX) on ipsilateral and contralateral testis damage caused by experimental testis torsion and detorsion. Materials and methods: Forty rats were divided into five groups (n = 8): control, torsion (T), torsion + desferrioxamine (T + DFX), torsion/detorsion (T/D), and torsion/detorsion + desferrioxamine (T/D + DFX). The right testes of the rats were subjected to torsion and detorsion for 3 h each. Thirty minutes before the application of torsion and detorsion, DFX (100 mg/kg) was administered intramuscularly. Blood samples and testicular tissues were examined using specific biochemical and histopathological methods. Results: Ipsilateral and contralateral testis tissue glutathione levels in the T group decreased compared with the control and T + DFX groups. Plasma glutathione peroxidase activity in the T, T/D, and T/D + DFX groups was lower than in the control group. Plasma catalase activity in the T and T/D groups decreased compared with the control group. Ipsilateral mean seminiferous tubule diameter of the T group was lower than that of the T + DFX group. The ipsilateral mean testis biopsy scores in the T and T/D groups were lower than in the control group. Conclusion: The administration of DFX prior to torsion may be useful only for preventing ischemic damage in ipsilateral and contralateral testes. (C) 2013 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.en
dc.description.urihttps://doi.org/10.1016/j.jpurol.2013.11.019
dc.identifier.doi10.1016/j.jpurol.2013.11.019
dc.identifier.eissn1873-4898
dc.identifier.endpage558
dc.identifier.issn1477-5131
dc.identifier.issue3
dc.identifier.pubmed24440694
dc.identifier.startpage550
dc.identifier.urihttps://hdl.handle.net/20.500.14981/53402
dc.identifier.volume10
dc.identifier.wos000339771000032
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.relation.ispartofJOURNAL OF PEDIATRIC UROLOGY
dc.subjectSpermatic cord torsion
dc.subjectIschemia
dc.subjectReperfusion injury
dc.subjectLIPID-PEROXIDATION
dc.subjectSUPEROXIDE-DISMUTASE
dc.subjectBLOOD-FLOW
dc.subjectINJURY
dc.subjectDEFEROXAMINE
dc.subjectANTIOXIDANTS
dc.subjectPRETREATMENT
dc.subjectGLUTATHIONE
dc.subjectDESFERROXAMINE
dc.subjectPediatrics
dc.subjectUrology & Nephrology
dc.titleDesferrioxamine effectively attenuates testicular tissue at the end of 3 h of ischemia but not in an equal period of reperfusion
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar